Sensex, Nifty finish at file excessive for second day in row


Mumbai, November 10

Equity benchmarks rallied to fresh lifetime highs on Tuesday, propelled by banking and finance stocks, after positive results from Pfizer’s Covid vaccine trials turbocharged global market sentiment.

Pfizer vaccine trials turbocharge markets

  • Climbing for the seventh session on the trot, the Sensex soared 680.22 points to close above the 43,000-mark for the first time at 43,277.65
  • Intra-day, the 30-share benchmark touched its lifetime peak of 43,316.44 points

  • The NSE Nifty too ended at its all-time high of 12,631.10, up 170.05 points. It hit an intra-day record of 12,643.90 during the session

Climbing for the seventh session on the trot, the Sensex soared 680.22 points to close above the 43,000-mark for the first time at 43,277.65. Intra-day, the 30-share benchmark touched its lifetime peak of 43,316.44.

The broader NSE Nifty too ended at its all-time high of 12,631.10, up 170.05 points or 1.36 per cent. It hit an intra-day record of 12,643.90 during the session.

Both the benchmarks scaled record highs for the second straight session.

Bajaj Finance was the top gainer in the Sensex pack, spurting 8.84%, followed by IndusInd Bank, L&T, Bajaj Finserv, HDFC, SBI, ICICI Bank, HDFC Bank, ONGC and Axis Bank. On the other hand, Tech Mahindra, HCL Tech, Nestle India, Infosys, Sun Pharma and TCS were among the main laggards, tumbling up to 5.73%.

Global equities witnessed a relief-rally after Pfizer and BioNTech on Monday said their vaccine candidate was found to be more than 90% effective in preventing Covid. — PTI



Be the first to comment on "Sensex, Nifty finish at file excessive for second day in row"

Leave a comment

Your email address will not be published.


*


%d bloggers like this: